Consumer healthcare giant Johnson & Johnson (J&J) has confirmed that it was pulling some versions of infant Tylenol off store shelves in the United States due to problems with new design of the bottles.
The company said it would recall all of the 574,000 redesigned bottles of grape-flavored liquid infant Tylenol.
The redesigned bottles of infant Tylenol included a plastic cover that was designed to make it easier for parents to extract the correct dose of the medicine with a plastic syringe.
But some parents complained that when they slotted the syringe into the top of the bottle, it shoved the cover right into the bottle, making it complicated to gauge the right quantity of the medicine.
Chief executive William Weldon claimed that was nothing incorrect with the medicine itself and that the company issued the latest recall to preserve and reinforce the company’s commitment to patients and consumers.
Since 2009, J&J has issued several recalls, pulling millions of bottles of Tylenol, Benadryl and Motrin off the store shelves due to problems such as metal shavings found in medicines, bad odors and wrong levels of an active ingredient.
- Postage Prices will Decrease from Sunday; USPS not too Happy About It
- Marriott and Starwood Hotels & Resorts Worldwide Inc Shareholders Approve to $14.41 Sales Deal
- UK plan to impose additional tax on sugary drinks
- Obesity during pregnancy may increase risk of very ‘large babies’
- Dropping Sales at Gap’s Key Brands hurt the Company’s Shares